Clinical Trials in Phoenix

Showing 9061-9080 of 16,646 trials

MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301

NCT02952001

This study is a non-interventional, observational extension of the Parent study, CLS1001-301 (NCT02595398). The purpose of this study is to characterize the continued clinical benefit(s) regarding safety and efficacy of suprachoroidally administered CLS-TA, triamcinolone acetonide injectable suspension, for the treatment of macular edema associated with non-infectious uveitis.

UveitisUveitis, PosteriorUveitis, Anterior+2 more

Clearside Biomedical, Inc.33 participantsStarted Dec 2017

Phoenix, Arizona, United States • Mountain View, California, United States • Fort Lauderdale, Florida, United States +13 more locations

COMPLETEDPhase 3< 1 mile

Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy

NCT02886728

The primary objective of this study is to evaluate the effects of filgotinib in combination with methotrexate (MTX) versus MTX alone in adults with active rheumatoid arthritis (RA).

Rheumatoid Arthritis

Gilead Sciences1,252 participantsStarted Aug 2016

Huntsville, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +183 more locations

MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301

Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy

Find Trials by Condition in Phoenix

2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)

Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease

BAX 855 PK-guided Dosing

A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, Food Effects, and Drug-drug Interactions of ACP-196 in Healthy Participants

Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)

Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

The BEACON Study (Breast Cancer Outcomes With NKTR-102)

Registry of Sustained Immunity to COVID-19 Among ESKD Patients

DEXYCU (Dexamethasone Intraocular Suspension) 9% Retrospective Study 001

Bupivacaine Effectiveness and Safety in SABER® Trial

Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients

A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL

Safety and Efficacy of RAD001 in Participants With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy

A Novel Approach to Infantile Spasms

Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T

Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)